187 related articles for article (PubMed ID: 24846933)
1. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding.
Eijgenraam P; ten Cate H; ten Cate-Hoek AJ
Neth J Med; 2014 Apr; 72(3):157-64. PubMed ID: 24846933
[TBL] [Abstract][Full Text] [Related]
2. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
4. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures.
Hammerstingl C; Omran H;
Thromb Haemost; 2009 Jun; 101(6):1085-90. PubMed ID: 19492151
[TBL] [Abstract][Full Text] [Related]
5. Perioperative complications in patients on low-molecular-weight heparin bridging therapy.
Breen DT; Chavalertsakul N; Paul E; Gruen RL; Serpell J
ANZ J Surg; 2016 Mar; 86(3):167-72. PubMed ID: 23336820
[TBL] [Abstract][Full Text] [Related]
6. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
7. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
Hammerstingl C; Omran H
Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
[TBL] [Abstract][Full Text] [Related]
8. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation bridging around device surgery: compliance with guidelines.
Perrin MJ; Vezi BZ; Ha AC; Keren A; Nery PB; Birnie DH
Pacing Clin Electrophysiol; 2012 Dec; 35(12):1480-6. PubMed ID: 22978770
[TBL] [Abstract][Full Text] [Related]
11. High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.
Leijtens B; Kremers van de Hei K; Jansen J; Koëter S
Arch Orthop Trauma Surg; 2014 Sep; 134(9):1335-41. PubMed ID: 24990654
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
[TBL] [Abstract][Full Text] [Related]
13. Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves.
Schulman JM; Majeed A; Mattsson E; Schulman S; Holmström M; Ågren A
J Thromb Thrombolysis; 2015 Nov; 40(4):430-6. PubMed ID: 25868460
[TBL] [Abstract][Full Text] [Related]
14. Adherence to guidelines for perioperative management of anticoagulation results in decreased bleeding complications: a single-centre experience.
DeSancho MT; Bardarova S; Chapin J
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):426-9. PubMed ID: 25699609
[TBL] [Abstract][Full Text] [Related]
15. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
17. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
[TBL] [Abstract][Full Text] [Related]
18. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients - a prospective cohort study.
Li BX; Liu SD; Qi L; Sun S; Sun W; Li YM; Song B; Wu XA
J Cardiothorac Surg; 2020 Feb; 15(1):40. PubMed ID: 32093747
[TBL] [Abstract][Full Text] [Related]
20. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
